End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,275 KRW | +1.79% | -32.36% | -23.11% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Precision Diagnosis Products
52.7
%
| 3,492 | 31.7 % | 2,293 | 52.7 % | -34.32% |
DTC
25.2
%
| 5,978 | 54.3 % | 1,096 | 25.2 % | -81.66% |
Research Service
17.1
%
| 301 | 2.7 % | 743 | 17.1 % | +146.99% |
Goods
4.5
%
| 1,227 | 11.1 % | 196 | 4.5 % | -84.06% |
Lease
0.5
%
| 20 | 0.2 % | 23 | 0.5 % | +11.76% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 11,018 | 100.0 % | 4,351 | 100.0 % | -60.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dae-Chul Choi
CEO | Chief Executive Officer | 52 | - |
Kwang-Joong Kim
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Se-Hyuk Yoon
PRN | Corporate Officer/Principal | 47 | - |
Hoon-Shik Kim
AUD | Comptroller/Controller/Auditor | 62 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mahn-Soon Hwang
BRD | Director/Board Member | 54 | - |
Young-Ho Moon
BRD | Director/Board Member | 62 | - |
Dae-Chul Choi
CEO | Chief Executive Officer | 52 | - |
Kwang-Joong Kim
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Gi-Won Kang
BRD | Director/Board Member | 61 | - |
Jun-Seok Choi
BRD | Director/Board Member | 52 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,889,227 | 8,454,468 ( 65.59 %) | 0 | 65.59 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-23.11% | 39.42M | |
+0.89% | 12.59B | |
-10.29% | 7.42B | |
+1.78% | 5.35B | |
-1.16% | 4.51B | |
+5.74% | 4.47B | |
-50.70% | 3.21B | |
+12.21% | 2.71B | |
-16.13% | 1.96B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- A354200 Stock
- Company NGeneBio Co., Ltd.